Hints and tips:
...The contracts will give the UK access to 1.75m additional courses of Merck Sharp and Dohme’s antiviral Lagevrio and an extra 2.5m courses of Pfizer’s Paxlovid pill....
...Merck Sector: PHARMA / HQ: KENILWORTH, us Merck faces a growth challenge because of the loss of exclusivity on its multibillion-dollar cancer drug Keytruda towards the end of the decade....
...It has also faced setbacks in European investments, notably in retail, but its successful exits include the $2.4bn sale of France’s Antelliq to Merck in December....
...A spokesperson for Merck Sharp & Dohme – the name under which the US group operates in Europe – said it is cooperating fully with the CMA’s investigation, and said: MSD is confident that the proceedings...
...Mergers led the US company to become known as Merck Sharp & Dohme, which prompted a 1950s agreement for it to keep exclusive rights to the Merck name in North America while calling itself MSD everywhere...
...Mergers led the US company to become known as Merck Sharp & Dohme, and this spurred a 1950s agreement for it to keep exclusive rights to the family name in North America while calling itself MSD everywhere...
...To closures by Merck Sharp & Dohme, GlaxoSmithKline, Roche and Pfizer has now been added AstraZeneca’s re-organisation and reduction....
...Merck Sharp and Dohme, better known as MSD, has filed a case with Delhi’s High Court claiming that Glenmark, the Mumbai-listed pharmaceutical company, is violating patents on its diabetes drugs, Januvia...
...Merck Sharp and Dohme sells its patented diabetes drug Januvia in India for about $24 per month, 80 per cent lower than its global price....
...Merck & Co seeks Chinese alliances Merck & Co,the second-largest US drugmaker is ditching the strategy of increasing sales employees in China and turning to local partners and education to reach doctors...
...Critics such as Steven Nissen, a cardiologist at the Cleveland Clinic in the US who three years ago helped stoke public and political concern – and a sharp drop in prescriptions – by suggesting that the...
...Analysis of the bidders’ operational performance one year before a deal and three years after the combined group was created showed a sharp deterioration....
...Merck, which had funded the study, benefited, but so too did Warner Lambert....
...Merck on Tuesday became the latest big pharma group to move into generics, a sharp break from its roots....
...Fuelled by safety concerns since the withdrawal in 2004 of Vioxx, Merck’s painkiller, and scares last year around Avandia, GlaxoSmithKline’s diabetes treatment, companies accuse the US Food & Drug Administration...
...Mr McNamee said domestic sales and royalties from international sales of Gardasil – CSL’s cervical cancer vaccine, which is licensed by Merck – had helped lift annual net profit by 30 per cent to A$702m....
...Last year, it bought Merck Sharp & Dohme’s Ponders End API manufacturing site in north London. It has not divulged details of either that deal or the Queenborough purchase....
...A drag on the Dow was Dupont , off 0.8 per cent at $50.50 and Merck, down 0.9 per cent at $50.23....
...Ranbaxy, which recently denied a suggestion that it had bid as much as €6bn for the business, has suffered a sharp drop in its share price since it announced its interest in the German unit....
...The gains would have been more impressive but for sharp afternoon selling of pharmaceutical group Merck , which lost 5.7 per cent to $38.83 after a state judge allowed a retrial for a man who blamed his...
...However, investors can withdraw shares already tendered to Bayer and Merck will hope to acquire them and build its stake to 50 per cent. Merck fell 2.7 per cent to €71.98....
...Among the large vaccine manufacturers, Merck of the US and Aventis Pasteur of France are most active in Aids research. Dr Berkley says a Merck vaccine in early-stage trials in the US is ?...
...In what could be a coincidence, Switzerland’s Novartis was again being named as a possible bidder for drugs group SkyePharma, as were AstraZeneca and Merck of the US....
...Tyco, the manufacturing group, fell 6.8 per cent after it reported a sharp fall in quarterly profits. General Electric, the diversified manufacturer, slipped 1 per cent over the week....
...AGF, which also reported a sharp rise in 2004 perofits and proposed a 44 per cent dividend increase, saw its shares gain 0.6 per cent to €58.65....
International Edition